BioScrip, Inc. Awarded National HIV/AIDS and Transplant Specialty Contract by UnitedHealthcare.ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS) announced today that UnitedHealthcare, a UnitedHealth Group (NYSE NYSE See: New York Stock Exchange : UNH Unh The symbol for the element unnilhexium. ) company, has awarded BioScrip an agreement to serve as one of two national specialty pharmacy providers of HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Solid Organ Transplant solid organ transplant Immunology A transplanted solid organ–eg, heart, liver, kidney, as contrasted to 'liquid' transplanted tissues–eg, BM, pancreatic islets. See Transplant, Transplantation. drugs and services to UnitedHealthcare and its participating affiliates. BioScrip expects that it will begin providing these services on August 1, 2007, with the initial term of the agreement running through December 31, 2008. HIV/AIDS In 2005, the United States Center for Disease Control ("CDC See Control Data, century date change and Back Orifice. CDC - Control Data Corporation ") estimated that there were between 1,039,000 to 1,185,000 people living with HIV/AIDS in the United States, with another 40,000 becoming infected each year. Additionally, a 2006 study estimates an average annual cost of care for a person living with HIV/AIDS to be $25,200, with 2/3 of that, or approximately $16,800, attributable to drug expenditures. Solid Organ Transplantation According to the 2006 OPTN OPTN Organ Procurement and Transplantation Network OPTN Operationalizing and Professionalizing the Network OPTN Option / SRTR SRTR Scientific Registry of Transplant Recipients SRTR Spouse's Renewable Term Rider Annual Report prepared by the Scientific Registry of Transplant Recipients (SRTR) in collaboration with the Organ Procurement and Transplantation Network (OPTN) under contract with the Health Resources and Services Administration The Health Resources and Services Administration (HRSA) is an agency within the United States Department of Health and Human Services whose goal is to improve access to health care for those without insurance. (HRSA HRSA Health Resources & Services Administration (US) HRSA Historical Radio Society of Australia HRSA Hamilton Rating Scale for Anxiety HRSA Hotel and Restaurant Suppliers Association (Canada) ), at the end of 2004, there were 153,245 people living with a functioning transplanted organ (kidney, pancreas, liver, heart, lung, intestine and heart-lung) in the United States. Additionally, in 2005, there were over 27,527 organs transplanted. Costs for post-transplant immunosuppressant drugs can exceed $13,000 annually, accordingly to a 2007 report. About UnitedHealthcare UnitedHealthcare (www.unitedhealthcare.com) provides a full spectrum of consumer-oriented health benefit plans and services. The company organizes access to quality, affordable health care services on behalf of more than 26 million individual consumers, contracting directly with more than 535,000 physicians and care professionals and 4,700 hospitals nationwide to offer them broad, convenient access to services nationwide. UnitedHealthcare is one of the businesses of UnitedHealth Group (NYSE: UNH), a diversified Fortune 50 health and well-being company. About BioScrip, Inc. BioScrip, Inc. (www.bioscrip.com) (Nasdaq: BIOS) is a specialty pharmaceutical health care organization that partners with patients, physicians, health care payors and pharmaceutical manufacturers to provide access to medications and management solutions to optimize outcomes for chronic and other complex health care conditions. Forward Looking Statements This press release may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company and our success with respect to the integration and consolidation. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission. |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion